Chescapmanager’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History

Chescapmanager’s Portfolio PRVL Stock Details PRVL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-255,407	Closed	-$5.89M	–	76
2020 Q4	$5.89M	Buy	+255,407	New	+$3.24M	0.72%	41

Chescapmanager's PRVL Position: Q1 2021 in Review

Chescapmanager sold out of Prevail Therapeutics Inc. Common Stock (PRVL) in Q1 2021, closing a stake of 255,407 shares — an estimated $5.89M sold.

Chescapmanager first reported a position in PRVL in Q4 2020 and held it in 1 quarter. The position peaked at $5.89M in Q4 2020. 0 funds tracked by Wall St. Rank hold PRVL as of Q1 2021.

Chescapmanager reported no remaining Prevail Therapeutics Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
Chescapmanager sold 255,407 Prevail Therapeutics Inc. Common Stock shares in Q1 2021, an estimated $5.89M.
Chescapmanager first reported a position in Prevail Therapeutics Inc. Common Stock in Q4 2020 and held it in 1 quarter.
Chescapmanager's Prevail Therapeutics Inc. Common Stock position peaked at $5.89M in Q4 2020.
0 funds tracked by Wall St. Rank held Prevail Therapeutics Inc. Common Stock as of Q1 2021.

Based on Chescapmanager's 13F filing for Q1 2021, filed 17 May 2021.